Trial intelligence / Profile preview

Risperidone and Trazodone for ICU Delirium

NCT02118688Phase 4Withdrawn

Sponsor
Rochester General Hospital
Start
Mar 2011
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of risperidone, trazodone in delirium, sponsored by Rochester General Hospital. Planned start Mar 2011; status: withdrawn.

02

Drugs

risperidonetrazodone
03

Conditions

delirium

Beyond the preview

Go deeper on NCT02118688.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02118688.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call